Articles by Sara Rogers, PharmD
Differentiating Pseudoprogression From Hyperprogression in Patients Treated With Immunotherapies
ByKashyap Patel, MD,Hirangi Mukhi, BS,Anjana Patel, BSc,Dhwani Mehta, MS,Natasha Clinton, MSN, APRN, AOCNP, BCMAS,Ben Brown,Sara Rogers, PharmD,William Oh, MD,Prasanth Reddy, MD, MPH Advances in the field have also led to the recognition of other clinical challenges, including unforeseen observations and complications associated with choosing the sequencing of appropriate therapeutic interventions as well as the management of drug-related complications.